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Complications of Venous Reconstruction in Human 
Orthotopic Liver Transplantation 
JAN LERUT, M.D., ANDREAS G. TZAKIS, M.D., KLAUS BRON, M.D., ROBERT D. GORDON, M.D., 
SHUNZABURO IWATSUKI, M.D., CARLOS O. ESQUIVEL, M.D., PH.D., LEONARD MAKOWKA, M.D., PH.D., 
SATORU TODO, M.D., and THOMAS E. STARZL, M.D., PH.D. 
In 313 consecutive recipients of 393 orthotopic liver grafts, there 
were 51 (16.3%) and nine (2.9%) patients who had pre-existing 
portal vein and inferior vena cava abnormalities, respectively. 
These abnormalities required adjustments in the transplant op-
eration and were a source of morbidity and mortality. The in-
cidence of thrombosis of the reconstructed portal vein was 1.8%. 
Only three (0.8%) vena caval thromboses were seen after 393 
liver replacements. Venous stenoses or disruptions were rare. 
Six women with the Budd-Cbiari syndrome bad liver replacement. 
Although this disorder is a veno-occIusive disease, five of the 
recipients achieved prolonged survival, only one bad recurrence 
of disease, and three are alive after 2-6 years. 
ALTHOUGH THE RESULTS after orthotopic liver transplantation (OLT) have greatly improved in 
recent years. 1-3 about 10% of the grafts are still 
lost from technical surgical complications of which the 
majority are hepatic artery thromboses and problems with 
biliary tract reconstruction. 1.4.5 A smaller number of liver 
recipients have pre-existing or postoperative defects of the 
portal venous or vena caval system. 1 
We report the number, nature, treatment, and outcome 
of these venous complications in a series of 393 OLTs 
performed on 313 consecutive patients who were given 
new livers after the introduction in 1980 of cyclosporine-
steroid therapy for immunosuppression. In addition, 
anomalies. congenital or acquired, of the vena cava, portal 
vein, and hepatic veins will be described as well as the 
technical modifications mandated by these anatomic 
variations. 
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Methods and Materials 
The 313 consecutive recipients were treated between 
March 1, 1980 and December 31, 1984. There were 177 
adults and 136 children. Sixty-eight patients had a second 
transplantation during the same period, and 12 patients 
required a third graft. All patients were followed for at 
least 1 year after OLT or until death. There were 33 deaths 
within the first 3 months including 12 intraoperative or 
perioperative deaths. Thus, 280 (89.4%) patients lived for 
more than 3 months after operation. 
Accounts have been published on the majority of these 
cases. 1-3 Immunosuppression was done with cyclosporine 
and steroids'·2 to which polyclonal antilymphocyte glob-
ulin (ALG) was occasionally added until the autumn of 
1983 for the control of intractible rejection. Since Sep-
tember 1984, monoclonal ALG (OKT3, Orthoclone®) has 
been used for the same purpose.6 In a small number of 
patients, azathioprine was added to maintenance therapy 
of cyclosporine and prednisone. 
In the following account, emphasis will be placed on 
details of donor and recipient management that had ob-
vious or potential implications for the venous reconstruc-
tions that are part of OLT. 
Recipient Workup 
Ultrasound examination of the recipient portal vein 
and inferior vena cava was routinely performed. In the 
event of ambiguous findings, or if it was believed that 
thrombosis of the portal vein had occurred, visualization 
404 
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of the vessel often was attempted with mesenteric an-
giography or by transhepatic catheterization of the portal 
vein. The inferior vena cava occasionally was studied by 
inferior vena cavography. 
Donor Operation 
The donor hepatectomies were part of a multiple organ 
procurement procedure previously described.? Cannulas 
that were used to infuse fluid into the portal vein were 
placed distally so the plastic material was not in contact 
with vein wall to be left in the recipient. Any abnormalities 
of the venous system were noted. At the end of the donor 
operation, free iliac arterial and venous grafts were always 
obtained? in case they were needed for the recipient op-
eration. Often, grafts of the inferior vena cava and ab-
dominal and/or thoracic aorta were also removed and 
stored in standard tissue culture medium. 
No effort was made to clean the liver graft perfectly 
during the donor operation. This work, including cleaning 
of the hepatic artery and portal vein and development of 
the venous anastomotic cuffs for their anastomoses, was 
done at the back table after the liver had been brought to 
the recipient operating room. 
Recipient Operation 
During the time when the diseased liver is being re-
moved and while the liver graft is being sewn into place, 
the portal vein and inferior vena cava must be obstructed. 
Since February 1983, a nonheparin pump-driven vena-
venous bypass has been used systematically in adults and 
in selected chidren to decompress the occluded venous 
pools. 8-10 Entry into the splanchnic venous system is with 
a plastic cannula inserted through the transected recipient 
portal vein. Entry into the inferior vena caval system is 
via a cannula inserted through the saphenous vein into 
the iliac venous system or distal inferior vena cava. The 
venous blood collected through these cannulas is pumped 
into the upper half ofthe body through a cannula inserted 
into the central axillary vein. 
The details of hepatectomy and of vascular reconstruc-
tion have been thoroughly described" 1.12 The native and 
grafted livers include a segment of the inferior vena cava 
from above the renal veins to the diaphragm. This segment 
removed with the native liver is replaced with the vena 
cava that comes with the liver graft. A cuff of the transected 
recipient vena cava at the diaphragm is fashioned by join-
ing the vena cava and the main hepatic veins into a 
cloaca. II In patients with cirrhosis, the hepatic veins may 
be drawn by fibrosis into the liver or into the diaphragm 
necessitating closure of one of the hepatic veins to obtain 
adequte cuff length. The backwall of both the upper and 
lower vena cava anastomoses must be sutured with an 
intraluminal technique. 1I •12 
One of the most disastrous mistakes that can be made 
in liver transplantation is to begin to sew the new liver in 
without having prepared adequate venous cuffs. With the 
venovenous bypass in place, it is possible to fashion vena 
caval cuffs and to skeletonize an adequate length of the 
portal vein while the bypass is functioning. If the tran-
sected portal vein contains new or old thrombus, it is 
necessary to consider a single venovenous bypass from 
the systemic system to the axillary vein. The penalty for 
using a splanchnic venous bypass in the presence of a 
portal thrombosis may be the propagation of a lethal pul-
monary embolus through the bypass system. 
If the portal vein has a major old thrombus, the most 
drastic resolution has been to dissect back the abnormal 
vessel to the junction of the splenic and superior mes-
enteric veins, to anastomose a free iliac vein graft from 
the donor onto the confluence of these tributaries, and to 
anastomose the portal vein of the new liver to the iliac 
vein graft. 13•14 . 
Great attention is paid to avoiding vascular anastomotic 
strictures, particularly of the portal vein and hepatic artery. 
Special techniques are used that leave extra Prolene® su-
ture material where the knots are tied so that the suture 
material can work its way back into the anastomosis after 
the vessels have been opened. This has been called the 
"growth factor technique" and it is particularly important 
with the small vessels of pediatric grafts and recipients. 15 
Retransplantation 
When retransplantation becomes necessary, the oper-
ation is greatly simplified if vascular cuffs from the first 
graft can be retained. A suprahepatic venous graft is almost 
always left in place, II and less commonly, a piece of in-
frahepatic vena cava from the first graft is retained. A 
graft of a previously placed portal vein was left behind in 
only nine of the 80 retransplantations, and an arterial 
remnant was used only three times. 
The foregoing techniques required modification in the 
event of anatomic abnormalities or variations. 
Results 
Pre-existing Abnormalities of the Inferior Vena Cava 
Nine (2.9%) of the 313 recipients had pre-existing ab-
normalities of the inferior vena cava. Five were children 
with biliary atresia (Table 1). In two of the five recipients, 
the inferior vena cava between the renal vein and the 
diaphragm was absent, and the main hepatic veins of the 
diseased liver emptied into a cloaca that communicated 
; , 
Q 
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TABLE 1. Pre-existing Inferior Vena Caval Abnormalities in Nine (2.9%) of J/J Recipients (/980-1984) 
Description of Abnormality 
Absent retrohepatic IYC (Fig. IA) 
Extrahepatic IYC; main hepatic veins 
into cloaca (Fig. IB) 
Absent superior vena cava: innominate 
vein drainage to IVC (Fig. 1 E) 
Thrombosis Ive 
Aneurysm Ive 
IVC = inferior vena cava. 
A c 
B o 
Liver Disease 
Biliary atresia 
Biliary atresia 
Biliary atresia 
Budd-Chiari syndrome 
After portal systemic shunt 
FIG. I. Abnormalities of the inferior vena cava (IVe) in children with 
biliary atresia. A. Absent retrohepatic Ive. B. Separated retrohepatic 
IVe. c. Technical adjustment for A. D. Technical adjustment for B. E. 
Anomalous drainage of innominate veins into the Ive (see text). 
No. of 
Patients 
2 
2 
2 
2 
Technical Adjustment(s) 
Suprahepatic graft lye anastomosis to recipient hepatic 
vein cloaca or right atrium: ligation infrahepatic lYe 
of graft (Fig. I e) 
Upper graft lye anastomosis to hepatic vein cloaca: 
ligation infrahepatic IVC of graft (Fig. 10) 
Anomaly not recognized: brain death resulted from 
innominate hypertension during IVC occlusion of 
anhepatic period 
Thrombectomy IVe, in one case including renal, iliac, 
and femoral veins 
Conventional lye anastomoses with adjustment for 
size discrepancy; shunt taken down 
directly with the right atrium (Fig. IA). In two other chil-
dren with biliary atresia, the retrohepatic inferior vena 
cava was present, but it was completely separate from the 
liver and its upper end received a cloaca into which all of 
the hepatic veins emptied (Fig. 1 B). In all four children, 
the upper vena cava cuff of the homograft was sutured to 
the hepatic vein cloaca, and the lower vena cava cuff of 
the graft was tied off or oversewn 11 (Figs. I C and D). Thus, 
the recipient operation was actually simpler than usual. 
There were no subsequent complications. Three of these 
four children also had hypoplasia or early extrahepatic 
bifurcation of the recipient portal vein (see later). 
A fifth child with biliary atresia was discovered at au-
topsy to have an absent superior vena cava with drainage 
of both innominate veins into the inferior vena cava below 
the renal veins (Fig. 1 E). During the anhepatic phase when 
the inferior vena cava was cross-clamped for about 40 
minutes, extreme venous hypertension in the craniofacial 
area developed, which caused irreversible brain damage 
and death 2 days later. 
In four adult patients (Table I), there were two ex-
amples each of inferior vena caval thrombosis and aneu-
rysmal dilatation. The thromboses, which in one patient 
extended to the renal, iliac, and femoral veins, were in 
patients with Budd-Chiari syndrome and were removed 
by thrombectomy at the time of the transplantation. Both 
women also had fresh thrombi in the portal vein. Vena-
venous bypass could not be used in either patient because 
of fear of pumping emboli to the lungs. There were no 
complications after transplantation. Both recipients were 
placed on chronic anticoagulant therapy. 
The two adults with aneurysmal dilatation of the in-
ferior vena cava had undergone previous portal systemic 
shunting. It was necessary to accept and correct 2: 1 and 
3: 1 size disparities in the lower vena caval anastomoses, 
but the results were satisfactory. The pre-existing portal 
systemic shunts were taken down. 
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TABLE 2. Portal Vein Abnormalities in 51 (16.3%) of 313 Recipients (1980-1984) 
No. of 
Patients Principal Association(s) Technical Adjustment(s) 
Thrombosis 22 
Hypoplasia 20 
9 none; 9 previous shunt or other hilar 
operation; 2 Budd-Chiari; 2 tumor 
14 biliary atresia *; 5 cirrhosis; one 
sclerosing cholangitis 
Thrombectomy; dissection to SV-SMV confluence; 
iliac vein or pulmonary artery graft to add length 
Dissection to SV-SMV confluence; vein graft 
sometimes 
Phlebosclerosis 8 4 previous shunt or other hilar operation; 
4 unknown 
Dissection to SV-SMV confluence; vein graft 
sometimes 
Absent portal vein Biliary atresia; previous hilar dissection Portacaval transposition 
* One patient also had very low bifurcation to right and left portal 
branches. 
Abnormalities a/the Portal Vein 
Surgically significant abnonnalities of the recipient 
portal vein were present in 51 (16.3%) of the 313 recipi-
ents. The most frequent and most serious condition was 
portal vein thrombosis (Table 2). A reason for the throm-
bosis was not obvious in nine patients, but in nine others 
there had been previous hilar dissections or attempts to 
control portal hypertension with portal-systemic shunts, 
splenectomy, or operations to interrupt venous collaterals. 
In one patient (Fig. 2), the portal vein had been tied off 
during hepatic lobectomy. Two patients with Budd-Chiari 
syndrome had relatively fresh thrombi that could be ex-
tracted easily, and there were two examples of tumor 
thrombi from hepatomas. 
Portal vein hypoplasia was found in 20 recipients of 
whom 14 had the diagnosis of biliary atresia with at least 
one previous attempt at portoenterostomy (Table 2). Hy-
poplasia was defined in pediatric patients by a portal vein 
diameter after full dissection ofless than 3.5 mm (Fig. 3). 
It was suspected that the development of collaterals in 
the adhesions that resulted from portoenterostomy in-
creased the "steal" of venous blood from the splanchnic 
bed, thereby promoting the involution of the portal vein 
in the hilum. The combined incidence of portal venous 
or vena caval abnormalities, or both, was 17 (23.3%) of 
72 children with biliary atresia. 
The other common portal venous abnormality was 
sclerosis (Table 2). This was a feature of the portal veins 
of patients who had previously undergone portal-systemic 
shunts, but it also was seen in previously unoperated re-
cipients. In two patients in whom an end-to-side porta-
caval shunt was taken down during transplantation, the 
calcium-containing wall of the sclerotic portal vein could 
not be sutured because of its fragility, and both patients 
bled to death in the operating room. 
The technical adjustments required by portal vein ab-
normalities included thrombectomy or retrograde dissec-
tion of the abnormal portal vein to the confluence of the 
splenic and superior mesenteric veins. Usually, the portal 
vein of the liver graft could be anastomosed to this con-
fluence, but in nine patients, a free graft of donor iliac 
SV = splenic vein. 
SMV = superior mesenteric vein. 
vein, pulmonary artery, or inferior vena cava was used to 
add length (Fig. 4). None of these grafts have failed to our 
knowledge. 
FIG. 2. Demonstration by transhepatic portography and enlarged sche-
matic representation of complete portal vein occlusion (OT 288). The 
portal vein had been tied off months previously during hepatic lobectomy. 
The reconstruction at the time of transplantation is shown in Figure 4. 
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portal v. 
Spleen 
FIG. 3, Portal vein hypoplasia (OT 228). Portal vein reconstruction was 
possible. 
Failure to provide an orthotopic graft with a portal ve-
nous inflow from the splanchnic bed has carried a 100% 
mortality rate. A caval-to-portal anastomosis was at-
tempted in one child in this series. The recipient inferior 
vena cava was brought anteriorly and anastomosed to the 
graft portal vein. This attempt and all similar previous 
trials have failed. In one recently treated patient not in-
cluded in this series. a long iliac vein graft was anasto-
mosed to the superior mesenteric vein well below the 
transverse mesocolon, brought up into the hilum behind 
the neck of the pancreas. and successfully anastomosed 
to the portal vein of the transplanted liver. 
The jeopardy in which previous operations can place 
the liver transplant recipient has been well recognized. I 
The adverse influence of procedures used to treat portal 
hypertension is seen in Table 3. Twenty-one (6.7%) of the 
313 recipients had undergone a portal-systemic shunt or 
splenectomy. In 14 of the 21 recipients. the portal vein 
was not normal at the time of transplantation, and in 
seven of these. the portal vein was thrombosed or absent. 
The technical adjustments made at the time of trans-
plantation were not successful in six of the 14 patients 
(Table 3). 
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FIG. 4. Selective angiography after transplantation confirms the patency 
of a venous vessel graft used for the patient depicted in Figure 2 (OT 
288). The recipient is well after 4 years. 
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TABLE 3. Relation between Previous Operations on the Splanchnic Circulation and Portal Vein Complications 
Type of Operation 
Portacaval shunt 
Central splenorenal shunt 
Mesocaval shunt 
Splenectomy 
Total 
No. of 
Patients 
7 
2 
3 
9 
21 
OL T = orthotopic liver transplantation. 
SV = splenic vein. 
Abnonnal Portal Vein 
atOLT 
3 thrombosed 
2 sclerotic 
2 small 
2 small 
3 thrombosed 
I sclerotic 
I absent 
14 
Shunts located at a distance from the hilum (spleno-
renal and mesocaval) caused less intraoperative danger 
and were taken down to ensure optimal blood supply to 
the liver (Table 3). 
Portal Vein Thrombosis 
A portal vein thrombosis developed after operation in 
seven (2.2%) of the 313 patients. The incidence relative 
to the 393 grafts was 1.8%. 
The pertinent features of the seven patients are shown 
in Table 4. Four of the seven recipients had a satisfactory 
early convalescence. The diagnosis was suspected or made 
when evidence of portal hypertension developed, includ-
ing variceal hemorrhage, persistence of esophageal varices 
on a barium swallow, and splenomegaly and hyper-
splenism. 
Portal flow was restored in only one of these four pa-
tients 8 months after transplantation. A high-grade ste-
nosis developed at the anastomosis in this patient (OT 
193) (Fig. 5). The portal vein thrombosed completely 
during the next few days. She had thrombectomy and 
reperformance of the portal vein anastomosis (Fig. 6). At 
this extraordinarily difficult operation, a partial biliary 
tract obstruction was also relieved. In a second patient, 
the esophageal varices were controlled with sclerotherapy 
alone (OT 226). In another recipient (Fig. 7), a distal sple-
norenal shunt became necessary because of recurrent 
nemorrhage 20 months after liver transplantation. In the 
tatter two patients, the hilar portal vein of the graft has 
oeen revascularized by venous collaterals so that there 
Nas a high volume of residual hepatopetal flow (Fig. 7, 
)ottom). 
The four patients whose early course was considered 
;atisfactory had a pre-existing and unrecognized throm-
Technical Solution 
Thrombectomy 
No solution 
Shunts ligated 
2 shunts ligated; I had 
thrombosed 
Thrombectomy and dissection 
to confluence ofSV-SMV 
Dissection to confluence 
Portacaval transposition 
SMV = superior mesenteric vein. 
Outcome 
I completely successful: 2 
thrombosed but 
survived (Table 4) 
2 died of bleeding 
2 survived 
2 survived 
I died late thrombosis 
I survived 
Died, no hepatic function 
bosis of the portal vein, splenic vein, and superior mes-
enteric vein. At the time of transplantation, thromqec-
tomy of the superior mesenteric vein was possible, but by 
the time angiography was performed 2 weeks later, the 
lumen was greatly attenuated in size, and much of the 
splanchnic flow was going through gastroesophageal col-
laterals (Fig. 8). When the patient died 14 months later, 
the portal vein and the superior mesenteric vein had 
clotted. 
The other three patients were desperately ill after op-
eration. Acute liver failure developed in two patients (OT 
259 and 273) and they were submitted to retransplanta-
tion; one patient survived. The third patient (OT 214) 
had retransplantation after chronic rejection of his first 
graft. At the time of the transplantation, there was a major 
size disparity between the donor and recipient, so great 
that the abdomen could not be closed. A Silastic® bag 
was placed over the wound temporarily, and closure af-
fected 2 days later. The reconstructed portal vein may 
have been buckled at that time. It was thrombosed 2 
months later at the time of autopsy. 
Four of the seven patients whose portal veins clotted 
are still alive, 3-5 years later; three patients have their 
original grafts and one patient was rescued with retrans-
plantation (Table 4). 
Vena Caval Thrombosis 
There were three postoperative inferior vena caval 
thromboses, all originating at the lower vena caval anas-
tomosis. The only survivor was the child whose portal 
vein was also clotted and who had prompt retransplan-
tation (Table 4). A second child died almost 4 months 
after transplantation with slowly declining liver function 
beginning 1 month after operation. This child had a car-
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diac arrest during performance of the lower vena caval 
anastomosis, and the suturing had been completed with 
the utmost dispatch under bad circumstances. The third 
patient had had multiple technical complications during 
a very difficult operation (Table 4). 
Portal Vein Pseudostenosis 
A 5-year-old boy (OT 286) had stenosis of the portal 
vein. His liver had been severely injured during procure-
ment and preservation with a serum oxaloacetic trans-
aminase level that rose to 10,000 IV on the first postop-
erative day. He required ventilatory support for 12 post-
v. 
SMV 
FIG. 5. Stenosis of the portal anastomosis diagnosed by transhepatic 
ponography. 
Portal v. 
FIG. 6. Treatment of the lesion shown in Figure 5 by resection of the 
stenosis. thrombectomy. and re-anastomosis (OLT \93). The patient is 
alive 5 years later. 
operative weeks. After recovering, angiography was 
obtained that seemed to show a high-grade stenosis at the 
portal vein anastomosis. A decision was made to defer 
reoperation, and 3 months later, repeat angiography 
showed a normal reconstructed portal vein. Three other 
examples of pseudostenosis have been seen, apparently 
because of anastomosis of smaller hypoplastic recipient 
portal veins to larger donor portal veins. 
Portal Vein Disruption 
A 47-year-old woman had disruption of a choledoch-
ocholedochostomy. The biliary fistula eroded the anterior 
wall of the portal vein anastomosis 2 weeks later causing 
a fatal hemorrhage. 
l 
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The Budd-Chiari Syndrome 
The six women with this diagnosis were 16-40 years 
old (mean: 26.1 ± 8.9 years SO). One patient died of 
infection 24 days after operation; but the other five pa-
tients had prolonged survival. One patient died at 452 
days of recurrent Budd-Chiari syndrome after anticoag-
ulant therapy was discontinued in preparation for a closed 
liver biopsy16; another death after 20 months was of a 
teenaged girl a few days after retransplantation for chronic 
rejection. 
The other three patients are alive after 2, 2, and 6 years, 
respectively. The survival of half of the patients was grat-
v. 
L. gastric v. 
" 
Collateral 
SMV" 
FIG. 7. Left top: percutaneous transhepatic portography showing extra 
hepatic portal vein thrombosis (OL T 218) I year after OL T. Right tor 
anatomy reconstructed from the radiographs shown on the left. leI 
bottom: selective angiography showing portal venous revascularizatiOI 
of the liver by venous collaterals I year after OL T. 
ifying because of the great technical difficulties encoun-
tered in all six patients. Two of the patients previously 
had undergone side-to-side portacaval shunts that had to 
be taken down at the time of transplantation, and two 
others had extensive thromboses of the portal vein and 
inferior vena cava that required thrombectomy. The latter 
two patients are still being carefully managed with Cou-
madin ill 2 years after transplantation. 
Discussion 
Most surgeons practicing today, and even those who 
are still young, will remember the pessimism with which 
Vol. 205 • No.4 COMPLICATIONS OF VENOUS RECONSTRUCTION IN OLT 413 
Donor"" 
portal v. 
, , 
","" 
Thrombus 
. 
411a, 
.... ..¥ 
., 
., 
'j.. I . 
./ 
It 
, 
, 
Recipient 
SMV 
FIG. 8. Severe stenosis of the mesenteric vein and important gastro-
esophageal collaterals at selective angiography 3 weeks after OL T (OT 
403). At the time of transplantation. phlebothrombectomy of the sple-
nomesenteric confluence had to be performed. 
grafting ofthe portal vein or inferior vena cava was viewed, 
whether using natural vessels or prostheses. 17.18 The doc-
trine that such grafts would easily clot was so pervasive 
that the venous system of hepatic homografts was seen 
by many early workers as the most important potential 
technical problem with liver replacement. Such concerns 
have become increasingly remote with the lack of venous 
complications in chronically surviving animals after liver 
replacement II and now with confirmatory human expe-
rience. 
In humans, thrombosis of either the portal vein or in-
ferior vena cava after liver replacement has been almost 
exclusively seen in pediatric recipients, and even in the 
smallest of these patients, thrombotic venous problems 
have been unusual. This low incidence has been all the 
more remarkable because of the common presence offac-
tors that could have, and possibly should have. predis-
posed to venous thrombosis. About one in six of the liver 
recipients has had an abnormal portal vein or vena cava 
to which the vessels of the new liver had to be anasto-
mosed, and in children with biliary atresia. the incidence 
of these dangerous situations has been one in four. 
Solutions to the pre-existing anatomic problems re-
quired a number of variations from the standard opera-
tion. The variations included the liberal use of free vein 
grafts in the portal system; none of these grafts are known 
to have clotted. In fact, the use of such free grafts would 
seem to be preferable in many situations to thrombectomy 
or other expedients in which a perfect technical result 
cannot be obtained. 
Finally. the success obtained with the Budd-Chiari syn-
drome, a disorder caused by pertubations of coagulation, 
is worth noting. Although one of the six recipients with 
this disease died early after operation of acute rejection, 
the other five had long survival without recurrent disease. 
In one of these patients whose chronic anticoagulant ther-
apy was unwisely stopped more than a year after opera-
tion, a lethal recurrence then developed. 16 
It could be speculated that the small number of graft 
thromboses reported here is only the visible part of a true 
incidence from which silent thromboses have been ex-
cluded. The argument could follow that the remarkably 
effective revascularization of the liver with collaterals after 
portal vein thrombosis documented in two of our patients 
could explain the retention of good liver perfusion and 
the preservation of hepatic function in other patients in 
whom the complication has not been diagnosed. 
However, there would be little justification for such a 
conclusion since real time ultrasonography has allowed 
discriminating study of all of the vascular structures of 
the graft in a noninvasive way. In our center, ultrasonog-
raphy is used repeatedly during the early convalescence 
to check the state of the various vessels, and it has become 
part of the late follow-up care. The increased use of the 
imaging techniques has been part of the background that 
has made liver transplantation increasingly practical. 19 
In the years ahead. the growth of the portal and vena 
caval systems of our many pediatric recipients will be ex-
ceptionally interesting to watch. A special technique has 
been used for all venous anastomoses. whereby slack is 
left in the Prolene suture used for the continuous anas-
• 
414 LERUT AND OTHERS Ann. Su ..... April 1981 
tomoses. IS This excess Prolene, euphemistically called a 
"growth factor," can be drawn slowly into an expanding 
anastomosis, keeping pace with growth needs. This was 
particularly well seen in one of our patients whose pseu-
dostricture at a portal venous anastomosis disappeared 
completely over a period of months at the same time as 
the disparity in donor and recipient vessel size corrected 
itself. This kind of adjustment is especially important in 
children with biliary atresia in whom a hypoplastic portal 
vein is the single most common pre-existing abnormality. 
The hypoplasia is probably due to shunting of blood away 
from the portal vein via collaterals established in the 
adhesions caused by portoenterostomy at an earlier age. 
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